MedTrace Logo

Proof-of-concept of the Measurement of Lung Function Using the Relaxed Expiratory Occlusion Monitor (REOM)

NCT04903145 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2021-05-27

No results posted yet for this study

Summary

(i) To validate the inversed occlusion technique by comparing the results of resistance obtained on the relaxed expiratory occlusion monitor (REOM) with the resistance obtained with respiratory oscillometry (OSC) measurements on the tremoflo® C-100 and (ii) explore (within-test and day-to-day) repeatability and responsiveness to change of this technique when used as home monitoring device in children with asthma.

Conditions

  • Asthma in Children

Interventions

DIAGNOSTIC_TEST

REOM

To compare data generated by the REOM device with data from the tremoflo C-100 device

Sponsors & Collaborators

  • MedTeq

    collaborator INDUSTRY

  • Thorasys Thoracic Medical Systems Inc.

    lead INDUSTRY

Principal Investigators

  • Francine M Ducharme, MD · St. Justine's Hospital

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2022-05-31
Completion
2022-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04903145 on ClinicalTrials.gov